185 related articles for article (PubMed ID: 18224727)
1. Blockage of intracellular proton extrusion with proton extrusions with proton pump inhibitor induces apoptosis in gastric cancer.
Yeo M; Kim DK; Park HJ; Cho SW; Cheong JY; Lee KJ
Cancer Sci; 2008 Jan; 99(1):185. PubMed ID: 18224727
[TBL] [Abstract][Full Text] [Related]
2. Selective induction of apoptosis with proton pump inhibitor in gastric cancer cells.
Yeo M; Kim DK; Kim YB; Oh TY; Lee JE; Cho SW; Kim HC; Hahm KB
Clin Cancer Res; 2004 Dec; 10(24):8687-96. PubMed ID: 15623654
[TBL] [Abstract][Full Text] [Related]
3. Proton pump inhibitor selectively suppresses proliferation and restores the chemosensitivity of gastric cancer cells by inhibiting STAT3 signaling pathway.
Huang S; Chen M; Ding X; Zhang X; Zou X
Int Immunopharmacol; 2013 Nov; 17(3):585-92. PubMed ID: 23973653
[TBL] [Abstract][Full Text] [Related]
4. Proton pump inhibitor pantoprazole inhibits the proliferation, self‑renewal and chemoresistance of gastric cancer stem cells via the EMT/β‑catenin pathways.
Feng S; Zheng Z; Feng L; Yang L; Chen Z; Lin Y; Gao Y; Chen Y
Oncol Rep; 2016 Dec; 36(6):3207-3214. PubMed ID: 27748935
[TBL] [Abstract][Full Text] [Related]
5. Revealing the Mechanistic Pathway of Acid Activation of Proton Pump Inhibitors To Inhibit the Gastric Proton Pump: A DFT Study.
Jana K; Bandyopadhyay T; Ganguly B
J Phys Chem B; 2016 Dec; 120(51):13031-13038. PubMed ID: 27992223
[TBL] [Abstract][Full Text] [Related]
6. Effects and mechanisms of proton pump inhibitors as a novel chemosensitizer on human gastric adenocarcinoma (SGC7901) cells.
Chen M; Zou X; Luo H; Cao J; Zhang X; Zhang B; Liu W
Cell Biol Int; 2009 Sep; 33(9):1008-19. PubMed ID: 19501661
[TBL] [Abstract][Full Text] [Related]
7. The H+/K+-ATPase inhibitory activities of Trametenolic acid B from Trametes lactinea (Berk.) Pat, and its effects on gastric cancer cells.
Zhang Q; Huang N; Wang J; Luo H; He H; Ding M; Deng WQ; Zou K
Fitoterapia; 2013 Sep; 89():210-7. PubMed ID: 23742858
[TBL] [Abstract][Full Text] [Related]
8. Proton pump inhibitor pantoprazole abrogates adriamycin-resistant gastric cancer cell invasiveness via suppression of Akt/GSK-β/β-catenin signaling and epithelial-mesenchymal transition.
Zhang B; Yang Y; Shi X; Liao W; Chen M; Cheng AS; Yan H; Fang C; Zhang S; Xu G; Shen S; Huang S; Chen G; Lv Y; Ling T; Zhang X; Wang L; Zhuge Y; Zou X
Cancer Lett; 2015 Jan; 356(2 Pt B):704-12. PubMed ID: 25449432
[TBL] [Abstract][Full Text] [Related]
9. Proton pump inhibitors induce apoptosis of human B-cell tumors through a caspase-independent mechanism involving reactive oxygen species.
De Milito A; Iessi E; Logozzi M; Lozupone F; Spada M; Marino ML; Federici C; Perdicchio M; Matarrese P; Lugini L; Nilsson A; Fais S
Cancer Res; 2007 Jun; 67(11):5408-17. PubMed ID: 17545622
[TBL] [Abstract][Full Text] [Related]
10. 7-O-Geranylquercetin induces apoptosis in gastric cancer cells via ROS-MAPK mediated mitochondrial signaling pathway activation.
Zhu Y; Jiang Y; Shi L; Du L; Xu X; Wang E; Sun Y; Guo X; Zou B; Wang H; Wang C; Sun L; Zhen Y
Biomed Pharmacother; 2017 Mar; 87():527-538. PubMed ID: 28076833
[TBL] [Abstract][Full Text] [Related]
11. The inhibitory effects of H+ K+ ATPase inhibitors on human neutrophils in vitro: restoration by a K+ ionophore.
Martins de Oliveira R; Antunes E; Pedrazzoli J; Gambero A
Inflamm Res; 2007 Mar; 56(3):105-11. PubMed ID: 17406807
[TBL] [Abstract][Full Text] [Related]
12. Suppression of phosphorylation of extracellular-signal-regulated kinase and p38 mitogen-activated protein kinase in polymorphonuclear leukocytes by the proton pump inhibitor lansoprazole.
Koshio O; Tansho S; Ubagai T; Nakaki T; Ono Y
J Infect Chemother; 2010 Apr; 16(2):100-6. PubMed ID: 20094750
[TBL] [Abstract][Full Text] [Related]
13. pH-dependent antitumor activity of proton pump inhibitors against human melanoma is mediated by inhibition of tumor acidity.
De Milito A; Canese R; Marino ML; Borghi M; Iero M; Villa A; Venturi G; Lozupone F; Iessi E; Logozzi M; Della Mina P; Santinami M; Rodolfo M; Podo F; Rivoltini L; Fais S
Int J Cancer; 2010 Jul; 127(1):207-19. PubMed ID: 19876915
[TBL] [Abstract][Full Text] [Related]
14. IL-33 Promotes Gastric Cancer Cell Invasion and Migration Via ST2-ERK1/2 Pathway.
Yu XX; Hu Z; Shen X; Dong LY; Zhou WZ; Hu WH
Dig Dis Sci; 2015 May; 60(5):1265-72. PubMed ID: 25655003
[TBL] [Abstract][Full Text] [Related]
15. Alpha-chaconine, a potato glycoalkaloid, induces apoptosis of HT-29 human colon cancer cells through caspase-3 activation and inhibition of ERK 1/2 phosphorylation.
Yang SA; Paek SH; Kozukue N; Lee KR; Kim JA
Food Chem Toxicol; 2006 Jun; 44(6):839-46. PubMed ID: 16387404
[TBL] [Abstract][Full Text] [Related]
16. Involvement of CaM-CaMKII-ERK in bisphenol A-induced Sertoli cell apoptosis.
Qian W; Zhu J; Mao C; Liu J; Wang Y; Wang Q; Liu Y; Gao R; Xiao H; Wang J
Toxicology; 2014 Oct; 324():27-34. PubMed ID: 24905940
[TBL] [Abstract][Full Text] [Related]
17. Proton pump inhibitors reduce interferon-γ-induced neurotoxicity and STAT3 phosphorylation of human astrocytes.
Hashioka S; Klegeris A; McGeer PL
Glia; 2011 May; 59(5):833-40. PubMed ID: 21360757
[TBL] [Abstract][Full Text] [Related]
18. Potential uses of intravenous proton pump inhibitors to control gastric acid secretion.
Metz DC
Digestion; 2000; 62(2-3):73-81. PubMed ID: 11025353
[TBL] [Abstract][Full Text] [Related]
19. ERK1/2 activation mediated by the nutlin‑3‑induced mitochondrial translocation of p53.
Lee SY; Shin SJ; Kim HS
Int J Oncol; 2013 Mar; 42(3):1027-35. PubMed ID: 23314357
[TBL] [Abstract][Full Text] [Related]
20. ERK1/2 inactivation and p38 MAPK-dependent caspase activation during guanosine 5'-triphosphate-mediated terminal erythroid differentiation of K562 cells.
Moosavi MA; Yazdanparast R; Lotfi A
Int J Biochem Cell Biol; 2007; 39(9):1685-97. PubMed ID: 17543571
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]